Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations

By sjmartinez • December 9, 2024

Seo YJ, Huston-Paterson HH, Schumm MA, Longstaff XR, Hughes EG, Tseng CH, Cheung DS, Yeh MW, Wu JX, Livhits MJ. Histopathologic And Clinical Features of Bethesda III-VI Nodules Harboring Isolated RAS Mutations. Endocr Pract. 2024 Dec 6:S1530-891X(24)00857-7. doi: 10.1016/j.eprac.2024.12.001. Epub ahead of print. PMID: 39647526.

Tags: BRAF V600E, Endocrinology, General Internal Medicine, molecular testing, Publications, RAS, recurrence, thyroid cancer

Closing the Distance: A Qualitative Study to Identify Equitable Innovations for Rural Thyroid Cancer Treatment

Huston-Paterson HH, Mao YV, Hughes EG, Bobanga I, Wu JX, Yeh MW. Closing the Distance: A Qualitative Study to Identify Equitable Innovations for Rural Thyroid[...]

A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver

Perry AS, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R, Stolze LK, Betti MJ, Zhao S, Huang S, Martens L, Kendall TJ, Thone[...]

Evaluation of dimethandrolone undecanoate in non-human primates as a candidate for long-acting injectable male contraceptive

Bunin DI, Kim K, Parman T, Gahagen J, Zelinski MB, Adevai T, Wang C, Tang L, Iyer L, Endsley A, Blithe DL, Lee MS. Evaluation[...]